A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
Chen Y, Li R, Duan Q, Wu L, Li X, Luo A, Zhang Y, Zhao N, Cui K, Wu W, Liu T, Wan JB, Deng L, Li G, Hou L, Tan W, Xiao Z.
Chen Y, et al. Among authors: cui k.
Adv Sci (Weinh). 2024 Aug;11(32):e2400149. doi: 10.1002/advs.202400149. Epub 2024 Jun 19.
Adv Sci (Weinh). 2024.
PMID: 38898748
Free PMC article.